Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2′-deoxyguanosine levels

Nephrology Dialysis Transplantation

Volumn 22, Issue 5, 2007, Pages 1407-1412

  Maruyama, Yukio ^a,c   Nakayama, Masaaki ^b   Yoshimura, Kazunobu ^a   Nakano, Hirofumi ^a   Yamamoto, Hiroyasu ^a   Yokoyama, Keitaro ^a   Lindholm, Bengt ^c  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

8 hydroxy 2 deoxyguanosine (8 OHdG); Anaemia; Haemodialysis; Intravenous iron administration; Oxidative stress

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FERRITIN; IRON; IRON SACCHARATE; RECOMBINANT ERYTHROPOIETIN;

ADULT; ANALYSIS OF VARIANCE; ANEMIA; ARTICLE; BLOOD LEVEL; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA DAMAGE; FEMALE; FERRITIN BLOOD LEVEL; HEMATOCRIT; HEMODIALYSIS PATIENT; HUMAN; IRON STORAGE; IRON THERAPY; MALE; MULTIPLE CYCLE TREATMENT; MULTIPLE REGRESSION; OXIDATIVE STRESS; PATIENT CODING; PATIENT MONITORING; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT DURATION;

ADULT; AGED; ANEMIA, IRON-DEFICIENCY; DEOXYGUANOSINE; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROPOIETIN, RECOMBINANT; FEMALE; FERRITINS; HEMATOCRIT; HUMANS; INFUSIONS, INTRAVENOUS; IRON; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RENAL DIALYSIS;

EID: 34447514131     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl789     Document Type: Article

References (20)

1. Langston RD, Presley R, Flanders WD, McClellan WM. Renal insufficiency and anemia are independent risk factors for death among patients with acute myocardial infarction. Kidney Int 2003; 64: 1398-1405
2. Horl WH, Cavill I, MacDougall IC, Schaefer RM, Sunder-Plassmann G. How to diagnose and correct iron deficiency during r-huEPO therapy - a consensus report. Nephrol Dial Transplant 1996; 11: 246-250
3. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis 2006; 47: S11-S145.
4. Rooyakkers TM, Stroes ES, Kooistra MP et al. Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo. Eur J Clin Invest 2002; 32 [Suppl 1]: 9-16
5. Tovbin D, Mazor D, Vorobiov M, Chaimovitz C, Meyerstein N. Induction of protein oxidation by intravenous iron in hemodialysis patients: Role of inflammation. Am J Kidney Dis 2002; 40: 1005-1012
6. Lim PS, Wei YH, Yu YL, Kho B. Enhanced oxidative stress in haemodialysis patients receiving intravenous iron therapy. Nephrol Dial Transplant 1999; 14: 2680-2687
7. Herrera J, Nava M, Romero F, Rodriguez-Iturbe B. Melatonin prevents oxidative stress resulting from iron and erythropoietin administration. Am J Kidney Dis 2001; 37: 750-757
8. Michelis R, Gery R, Sela S et al. Carbonyl stress induced by intravenous iron during haemodialysis. Nephrol Dial Transplant 2003; 18: 924-930
9. Kasai H. Analysis of a form of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res 1997; 387: 147-163
10. Tarng DC, Huang TP, Wei YH et al. 8-hydroxy-2′-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients. Am J Kidney Dis 2000; 36: 934-944
11. Kalantar-Zadeh K, Don BR, Rodriguez RA, Humphreys MH. Serum ferritin is a marker of morbidity and mortality in hemodialysis patients. Am J Kidney Dis 2001; 37: 564-572
12. Toyokuni S, Tanaka T, Hattori Y et al. Quantitative immunohistochemical determination of 8-hydroxy-2′-deoxyguanosine by a monoclonal antibody N45.1: Its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest 1997; 76: 365-374
13. Ponka P, Beaumont C, Richardson DR. Function and regulation of transferrin and ferritin. Semin Hematol 1998; 35: 35-54
14. Nakano M, Kawanishi Y, Kamohara S et al. Oxidative DNA damage (8-hydroxydeoxyguanosine) and body iron status: A study on 2507 healthy people. Free Radic Biol Med 2003; 35: 826-832
15. Tarng DC, Huang TP, Liu TY et al. Effect of vitamin E-bonded membrane on the 8-hydroxy 2′-deoxyguanosine level in leukocyte DNA of hemodialysis patients. Kidney Int 2000; 58: 790-799
16. Tarng DC, Wen Chen T, Huang TP et al. Increased oxidative damage to peripheral blood leukocyte DNA in chronic peritoneal dialysis patients. J Am Soc Nephrol 2002; 13: 1321-1330
17. Yoshimura K, Nakano H, Yokoyama K, Nakayama M. High iron storage levels are associated with increased DNA oxidative injury in patients on regular hemodialysis. Clin Exp Nephrol 2005; 9: 158-163
18. Kalantar-Zadeh K, Don BR, Rodriguez RA, Humphreys MH. Serum ferritin is a marker of morbidity and mortality in hemodialysis patients. Am J Kidney Dis 2001; 37: 564-572
19. Michaels ML, Tchou J, Grollman AP, Miller JH. A repair system for 8-oxo-7,8-dihydrodeoxyguanine. Biochemistry 1992; 31: 10964-10968
20. Zager RA, Johnson AC, Hanson SY. Parenteral iron nephrotoxicity: potential mechanisms and consequences. Kidney Int 2004; 66: 144-156